NIAID Banner Logo Image

Opportunistic Infections Citation List: August 30 - September 12, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Phytochemical, Antimicrobial and Antiprotozoal Evaluation of Garcinia mangostana Pericarp and Alpha-mangostin, Its Major Xanthone Derivative. Al-Massarani, S.M., A.A. El Gamal, N.M. Al-Musayeib, R.A. Mothana, O.A. Basudan, A.J. Al-Rehaily, M. Farag, M.H. Assaf, K.H. El Tahir, and L. Maes. Molecules, 2013. 18(9): p. 10599-10608. PMID[24002136].

[PubMed]. OI_0830-091213.


2. Synthesis, Structure and Antifungal Activity of Thiophene-2,3-dicarboxaldehyde bis(thiosemicarbazone) and Nickel(II), Copper(II) and Cadmium(II) Complexes: Unsymmetrical Coordination Mode of Nickel Complex. Alomar, K., A. Landreau, M. Allain, G. Bouet, and G. Larcher. Journal of Inorganic Biochemistry, 2013. 126: p. 76-83. PMID[23792913].

[PubMed]. OI_0830-091213.


3. Synthesis and Antifungal Activity of Terpenyl-1,4-naphthoquinone and 1,4-Anthracenedione Derivatives. Castro, M.A., A.M. Gamito, V. Tangarife-Castano, B. Zapata, J.M. Miguel Del Corral, A.C. Mesa-Arango, L. Betancur-Galvis, and A. San Feliciano. European Journal of Medicinal Chemistry, 2013. 67: p. 19-27. PMID[23831506].

[PubMed]. OI_0830-091213.


4. Isavuconazole Activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, Emerging Fungal Pathogens with Reduced Azole Susceptibility. Datta, K., P. Rhee, E. Byrnes, 3rd, G. Garcia-Effron, D.S. Perlin, J.F. Staab, and K.A. Marr. Journal of Clinical Microbiology, 2013. 51(9): p. 3090-3093. PMID[23804388].

[PubMed]. OI_0830-091213.


5. Phylogenetic Diversity and Antimicrobial Activity of Marine Bacteria Associated with the Soft Coral Sarcophyton glaucum. Elahwany, A.M., H.A. Ghozlan, H.A. Elsharif, and S.A. Sabry. Journal of Basic Microbiology, 2013. [Epub ahead of print]. PMID[23996153].

[PubMed]. OI_0830-091213.


6. Synthesis and Characterization of Novel Organocobaloximes as Potential Catecholase and Antimicrobial Activity Agents. Erdem-Tuncmen, M., F. Karipcin, and B. Sariboga. Archiv der Pharmazie (Weinheim), 2013. [Epub ahead of print]. PMID[24003018].

[PubMed]. OI_0830-091213.


7. Activity of Antifungal Combinations against Aspergillus Species Evaluated by Isothermal Microcalorimetry. Furustrand Tafin, U., C. Orasch, and A. Trampuz. Diagnostic Microbiology and Infectious Disease, 2013. 77(1): p. 31-36. PMID[23871413].

[PubMed]. OI_0830-091213.>

8. Two Peptides, TsAP-1 and TsAP-2, from the Venom of the Brazilian Yellow Scorpion, Tityus serrulatus: Evaluation of Their Antimicrobial and Anticancer Activities. Guo, X., C. Ma, Q. Du, R. Wei, L. Wang, M. Zhou, T. Chen, and C. Shaw. Biochimie, 2013. 95(9): p. 1784-1794. PMID[23770440].

[PubMed]. OI_0830-091213.


9. Phenyl Aldehyde and Propanoids Exert Multiple Sites of Action Towards Cell Membrane and Cell Wall Targeting Ergosterol in Candida albicans. Khan, M.S., I. Ahmad, and S.S. Cameotra. AMB Express, 2013. 3(1): p. 54. PMID[24010721].

[PubMed]. OI_0830-091213.


10. Chaetochromones A and B, Two New Polyketides from the Fungus Chaetomium indicum (CBS.860.68). Lu, K., Y. Zhang, L. Li, X. Wang, and G. Ding. Molecules, 2013. 18(9): p. 10944-10952. PMID[24013408].

PubMed]. OI_0830-091213.


11. Nystatin Nanosizing Enhances in Vitro and in Vivo Antifungal Activity against Candida albicans. Melkoumov, A., M. Goupil, F. Louhichi, M. Raymond, L. de Repentigny, and G. Leclair. The Journal of Antimicrobial Chemotherapy, 2013. 68(9): p. 2099-2105. PMID[23620465].

[PubMed]. OI_0830-091213.


12. Comparison of the Vitek 2 Yeast Susceptibility System with CLSI Microdilution for Antifungal Susceptibility Testing of Fluconazole and Voriconazole against Candida spp., Using New Clinical Breakpoints and Epidemiological Cutoff Values. Pfaller, M.A., D.J. Diekema, G.W. Procop, and M.G. Rinaldi. Diagnostic Microbiology and Infectious Disease, 2013. 77(1): p. 37-40. PMID[23870164].

[PubMed]. OI_0830-091213.


13. Anti-candida Properties of Asaronaldehyde of Acorus gramineus Rhizome and Three Structural Isomers. Rajput, S.B., R.B. Shinde, M.M. Routh, and S.M. Karuppayil. Chinese Medicine, 2013. 8(1): p. 18. PMID[24010893].

[PubMed]. OI_0830-091213.


14. Synthesis and Antifungal Activities of Miltefosine Analogs. Ravu, R.R., Y.L. Chen, M.R. Jacob, X. Pan, A.K. Agarwal, S.I. Khan, J. Heitman, A.M. Clark, and X.C. Li. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4828-4831. PMID[23891181].

[PubMed]. OI_0830-091213.


15. Anti-biofilm Activity of Low-molecular Weight Chitosan Hydrogel against Candida Species. Silva-Dias, A., A. Palmeira-de-Oliveira, I.M. Miranda, J. Branco, L. Cobrado, M. Monteiro-Soares, J.A. Queiroz, C. Pina-Vaz, and A.G. Rodrigues. Medical Microbiology and Immunology, 2013. [Epub ahead of print]. PMID[24013184].

[PubMed]. OI_0830-091213.


16. Bioassay-guided Fractionation of Extracts from Hypericum perforatum in Vitro Roots Treated with Carboxymethylchitosans and Determination of Antifungal Activity against Human Fungal Pathogens. Tocci, N., F.D. D'Auria, G. Simonetti, S. Panella, A.T. Palamara, A. Debrassi, C.A. Rodrigues, V.C. Filho, F. Sciubba, and G. Pasqua. Plant Physiology and Biochemistry, 2013. 70: p. 342-347. PMID[23811777].

[PubMed]. OI_0830-091213.


17. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as Inhibitors of Tyrosyl-tRNA Synthetase: Synthesis, Molecular Docking and Antibacterial Evaluation. Wang, X.D., R.C. Deng, J.J. Dong, Z.Y. Peng, X.M. Gao, S.T. Li, W.Q. Lin, C.L. Lu, Z.P. Xiao, and H.L. Zhu. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 4914-4922. PMID[23891164].

[PubMed]. OI_0830-091213.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

18. Potential Antimicrobial Agents for the Treatment of MDR-TB. Alsaad, N., B. Wilffert, R. van Altena, W.C. de Lange, T.S. van der Werf, J.G. Kosterink, and J.W. Alffenaar. The European Respiratory Journal, 2013. [Epub ahead of print]. PMID[23988774].

[PubMed]. OI_0830-091213.


19. Synthesis and Antimycobacterial Activity of Analogues of the Bioactive Natural Products Sampangine and Cleistopholine. Claes, P., D. Cappoen, B.M. Mbala, J. Jacobs, B. Mertens, V. Mathys, L. Verschaeve, K. Huygen, and N. De Kimpe. European Journal of Medicinal Chemistry, 2013. 67: p. 98-110. PMID[23850570].

[PubMed]. OI_0830-091213.


20. Low-Dose Aspirin and Ibuprofen's Sterilizing Effects on Mycobacterium tuberculosis Suggest Safe New Adjuvant Therapies for Tuberculosis. Eisen, D.P., E.S. McBryde, and A. Walduck. The Journal of Infectious Diseases, 2013. [Epub ahead of print]. PMID[23997233].

[PubMed]. OI_0830-091213.


21. Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis. Fillion, A., A. Aubry, F. Brossier, A. Chauffour, V. Jarlier, and N. Veziris. Antimicrobial Agents and Chemotherapy, 2013. 57(9): p. 4496-4500. PMID[23836169].

[PubMed]. OI_0830-091213.


22. Synthesis and Structure-Activity Relationships Evaluation of Benzothiazinone Derivatives as Potential Anti-tubercular Agents. Gao, C., T.H. Ye, N.Y. Wang, X.X. Zeng, L.D. Zhang, Y. Xiong, X.Y. You, Y. Xia, Y. Xu, C.T. Peng, W.Q. Zuo, Y. Wei, and L.T. Yu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4919-4922. PMID[23886691].

[PubMed]. OI_0830-091213.


23. In Vitro Antimicrobial Activity of Squalamine Derivatives against Mycobacteria. Ghodbane, R., S.M. Ameen, M. Drancourt, and J.M. Brunel. Tuberculosis, 2013. 93(5): p. 565-566. PMID[23735598].

[PubMed]. OI_0830-091213.


24. Assessment of Clofazimine Activity in a Second-line Regimen for Tuberculosis in Mice. Grosset, J.H., S. Tyagi, D.V. Almeida, P.J. Converse, S.Y. Li, N.C. Ammerman, W.R. Bishai, D. Enarson, and A. Trebucq. American Journal of Respiratory and Critical Care Medicine, 2013. 188(5): p. 608-612. PMID[23822735].

[PubMed]. OI_0830-091213.


25. Synthesis of Novel Isothiazolopyridines and Their in Vitro Evaluation against Mycobacterium and Propionibacterium acnes. Malinka, W., P. Swiatek, M. Sliwinska, B. Szponar, A. Gamian, Z. Karczmarzyk, and A. Fruzinski. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 5282-5291. PMID[23850103].

[PubMed]. OI_0830-091213.


26. Synthesis and Bioevaluation of Some New Isoniazid Derivatives. Matei, L., C. Bleotu, I. Baciu, C. Draghici, P. Ionita, A. Paun, M.C. Chifiriuc, A. Sbarcea, and I. Zarafu. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 5355-5361. PMID[23823011].

[PubMed]. OI_0830-091213.


27. Antimycobacterial and Photosynthetic Electron Transport Inhibiting Activity of Ring-substituted 4-Arylamino-7-chloroquinolinium chlorides. Otevrel, J., P. Bobal, I. Zadrazilova, R. Govender, M. Pesko, S. Keltosova, P. Koleckarova, P. Marsalek, A. Imramovsky, A. Coffey, J. O'Mahony, P. Kollar, A. Cizek, K. Kralova, and J. Jampilek. Molecules, 2013. 18(9): p. 10648-10670. PMID[24002140].

[PubMed]. OI_0830-091213.


28. Synthesis and Structure Activity Relationship of Imidazo[1,2-a]pyridine-8-carboxamides as a Novel Antimycobacterial Lead Series. Ramachandran, S., M. Panda, K. Mukherjee, N.R. Choudhury, S.J. Tantry, C.K. Kedari, V. Ramachandran, S. Sharma, V.K. Ramya, S. Guptha, and V.K. Sambandamurthy. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4996-5001. PMID[23867166].

[PubMed]. OI_0830-091213.


29. Inhibition of Mycobacterium tuberculosis Strains H37Rv and MDR MS-115 by a New Set of C5 Modified Pyrimidine Nucleosides. Shmalenyuk, E.R., L.N. Chernousova, I.L. Karpenko, S.N. Kochetkov, T.G. Smirnova, S.N. Andreevskaya, A.O. Chizhov, O.V. Efremenkova, and L.A. Alexandrova. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 4874-4884. PMID[23891229].

[PubMed]. OI_0830-091213.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

30. Synthesis and Antiprotozoal Activity of Original Porphyrin Precursors and Derivatives. Abada, Z., S. Cojean, S. Pomel, L. Ferrie, B. Akagah, A.T. Lormier, P.M. Loiseau, and B. Figadere. European Journal of Medicinal Chemistry, 2013. 67: p. 158-165. PMID[23851117].

[PubMed]. OI_0830-091213.


31. The Effect of Novel [3-Fluoro-(2-phosphonoethoxy)propyl]purines on the Inhibition of Plasmodium falciparum, Plasmodium vivax and Human hypoxanthine-guanine-(xanthine) Phosphoribosyltransferases. Baszczynski, O., D. Hockova, Z. Janeba, A. Holy, P. Jansa, M. Dracinsky, D.T. Keough, and L.W. Guddat. European Journal of Medicinal Chemistry, 2013. 67: p. 81-89. PMID[23850568].

[PubMed]. OI_0830-091213.


32. A Plasmodium falciparum Screening Assay for Anti-gametocyte Drugs Based on Parasite Lactate Dehydrogenase Detection. D'Alessandro, S., F. Silvestrini, K. Dechering, Y. Corbett, S. Parapini, M. Timmerman, L. Galastri, N. Basilico, R. Sauerwein, P. Alano, and D. Taramelli. The Journal of Antimicrobial Chemotherapy, 2013. 68(9): p. 2048-2058. PMID[23645588].

[PubMed]. OI_0830-091213.


33. Improvement of the Efficacy of Dihydroartemisinin with Atorvastatin in an Experimental Cerebral Malaria Murine Model. Dormoi, J., S. Briolant, A. Pascual, C. Desgrouas, C. Travaille, and B. Pradines. Malaria Journal, 2013. 12(1): p. 302. PMID[23988087].

[PubMed]. OI_0830-091213.


34. Antiprotozoal Activity of Bicyclic Diamines with a N-Methylpiperazinyl Group at the Bridgehead Atom. Faist, J., W. Seebacher, M. Kaiser, R. Brun, R. Saf, and R. Weis. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 4988-4996. PMID[23880082].

[PubMed]. OI_0830-091213.


35. Synthesis of Novel Analogs of 2-Pyrazoline Obtained from [(7-Chloroquinolin-4-yl)amino]chalcones and Hydrazine as Potential Antitumor and Antimalarial Agents. Insuasty, B., A. Montoya, D. Becerra, J. Quiroga, R. Abonia, S. Robledo, I.D. Velez, Y. Upegui, M. Nogueras, and J. Cobo. European Journal of Medicinal Chemistry, 2013. 67: p. 252-262. PMID[23871905].

[PubMed]. OI_0830-091213.


36. Synthesis and Antiprotozoal Activities of Benzyl phenyl ether diamidine Derivatives. Patrick, D.A., S.A. Bakunov, S.M. Bakunova, S.K. Jones, T. Wenzler, T. Barszcz, A. Kumar, D.W. Boykin, K.A. Werbovetz, R. Brun, and R.R. Tidwell. European Journal of Medicinal Chemistry, 2013. 67: p. 310-324. PMID[23871911].

[PubMed]. OI_0830-091213.


37. Synthesis of Polysubstituted Benzofuran Derivatives as Novel Inhibitors of Parasitic Growth. Thevenin, M., S. Thoret, P. Grellier, and J. Dubois. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 4885-4892. PMID[23902828].

[PubMed]. OI_0830-091213.


38. Tetrazole-based Deoxyamodiaquines: Synthesis, ADME/PK Profiling and Pharmacological Evaluation as Potential Antimalarial Agents. Tukulula, M., M. Njoroge, G.C. Mugumbate, J. Gut, P.J. Rosenthal, S. Barteau, J. Streckfuss, O. Heudi, J. Kameni-Tcheudji, and K. Chibale. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 4904-4913. PMID[23896611].

[PubMed]. OI_0830-091213.


39. Cell-based Medicinal Chemistry Optimization of High Throughput Screening Hits for Orally Active Antimalarials. Part 2: Hits from SoftFocus Kinase and Other Libraries. Younis, Y., L.J. Street, D. Waterson, M.J. Witty, and K. Chibale. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23927599].

[PubMed]. OI_0830-091213.


40. Farnesides A and B, Sesquiterpenoid Nucleoside Ethers from a Marine-derived Streptomyces sp., Strain CNT-372 from Fiji. Zafrir Ilan, E., M.R. Torres, J. Prudhomme, K. Le Roch, P.R. Jensen, and W. Fenical. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23987585].

[PubMed]. OI_0830-091213.

Citations from the ISI Web of Knowledge Listings for O.I.

41. A Novel Amalgamation of 1,2,3-Triazoles, Piperidines and Thieno Pyridine Rings and Evaluation of Their Antifungal Activity. Darandale, S.N., N.A. Mulla, D.N. Pansare, J.N. Sangshetti, and D.B. Shinde. European Journal of Medicinal Chemistry, 2013. 65: p. 527-532. ISI[000322850100051].

[WOS]. OI_0830-091213.


42. Microwave Assisted Synthesis of New Coumarin Based 3-Cyanopyridine Scaffolds Bearing Sulfonamide Group Having Antimicrobial Activity. Desai, N.C., H.M. Satodiya, K.M. Rajpara, V.V. Joshi, and H.V. Vaghani. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2013. 52(7): p. 904-914. ISI[000322358100003].

[WOS]. OI_0830-091213.


43. Chemical Screening Identifies Filastatin, a Small Molecule Inhibitor of Candida albicans Adhesion, Morphogenesis, and Pathogenesis. Fazly, A., C. Jain, A.C. Dehner, L. Issi, E.A. Lilly, A. Ali, H. Cao, P.L. Fidel, R.P. Rao, and P.D. Kaufman. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(33): p. 13594-13599. ISI[000323069200082].

[WOS]. OI_0830-091213.


44. Membrane Active Chelators as Novel Anti-african Trypanosome and Anti-malarial Drugs. Grab, D.J., E. Nenortas, R.P. Bakshi, O.V. Nikolskaia, J.E. Friedman, and T.A. Shapiro. Parasitology International, 2013. 62(5): p. 461-463. ISI[000322944200011].

[WOS]. OI_0830-091213.


45. Identification of Dihydroorotate Dehydrogenase as a Relevant Drug Target for 1-Hydroxyquinolones in Toxoplasma gondii. Hegewald, J., U. Gross, and W. Bohne. Molecular and Biochemical Parasitology, 2013. 190(1): p. 6-15. ISI[000323186600002].

[WOS]. OI_0830-091213.


46. Discovery of a Novel Dual Fungal CYP51/Human 5-Lipoxygenase Inhibitor: Implications for Anti-fungal Therapy. Hoobler, E.K., G. Rai, A.G.S. Warrilow, S.C. Perry, C.J. Smyrniotis, A. Jadhav, A. Simeonov, J.E. Parker, D.E. Kelly, D.J. Maloney, S.L. Kelly, and T.R. Holman. Plos One, 2013. 8(6): p. e65928 . ISI[000321738400006].

[WOS]. OI_0830-091213.


47. Synthesis and Biological Evaluation of 3-(4-Chlorophenyl)-4-substituted pyrazole Derivatives. Horrocks, P., M.R. Pickard, H.H. Parekh, S.P. Patel, and R.B. Pathak. Organic & Biomolecular Chemistry, 2013. 11(29): p. 4891-4898. ISI[000322299100018].

[WOS]. OI_0830-091213.


48. In Vitro Antiviral Activity of Plant Extracts from Asteraceae Medicinal Plants. Jaime, M.F.V., F. Redko, L.V. Muschietti, R.H. Campos, V.S. Martino, and L.V. Cavallaro. Virology Journal, 2013. 10: p. 245. ISI[000322601400001].

[WOS]. OI_0830-091213.


49. Design and Synthesis of Biquinolone-Isoniazid Hybrids as a New Class of Antitubercular and Antimicrobial Agents. Jardosh, H.H. and M.P. Patel. European Journal of Medicinal Chemistry, 2013. 65: p. 348-359. ISI[000322850100034].

[WOS]. OI_0830-091213.


50. Identification of Antifungal Niphimycin from Streptomyces sp. KP6107 by Screening Based on Adenylate Kinase Assay. Kim, H.Y., J. Do Kim, J.S. Hong, J.H. Ham, and B.S. Kim. Journal of Basic Microbiology, 2013. 53(7): p. 581-589. ISI[000323227300005].

[WOS]. OI_0830-091213.


51. Syntheses, Protonation Constants and Antimicrobial Activity of 2-Substituted N-alkylimidazole Derivatives. Kleyi, P., R.S. Walmsley, I.Z. Gundhla, T.A. Walmsley, T.I. Jauka, J. Dames, R.B. Walker, N. Torto, and Z.R. Tshentu. South African Journal of Chemistry, 2012. 65: p. 231-238. ISI[000322108300028].

[WOS]. OI_0830-091213.


52. Targeting Iron Acquisition Blocks Infection with the Fungal Pathogens Aspergillus fumigatus and Fusarium oxysporum. Leal, S.M., S. Roy, C. Vareechon, S.D. Carrion, H. Clark, M.S. Lopez-Berges, A. diPietro, M. Schrettl, N. Beckmann, B. Redl, H. Haas, and E. Pearlman. Plos Pathogens, 2013. 9(7): p. e1003436 . ISI[000322316700010].

[WOS]. OI_0830-091213.


53. Isoniazid-Gelatin Conjugate Microparticles Containing Rifampicin for the Treatment of Tuberculosis. Manca, M.L., R. Cassano, D. Valenti, S. Trombino, T. Ferrarelli, N. Picci, A.M. Fadda, and M. Manconi. Journal of Pharmacy and Pharmacology, 2013. 65(9): p. 1302-1311. ISI[000322869700003].

[WOS]. OI_0830-091213.


54. A Novel Combinatorial Biocatalytic Approach for Producing Antibacterial Compounds Effective against Mycobacterium tuberculosis (TB). McClay, K., B.J. Wan, Y.H. Wang, S. Cho, J. Yu, B. Santarsiero, S. Mehboob, M. Johnson, S. Franzblau, and R. Steffan. Applied Microbiology and Biotechnology, 2013. 97(16): p. 7151-7163. ISI[000322408100008].

[WOS]. OI_0830-091213.


55. Combined Efficacy of Biologically Synthesized Silver Nanoparticles and Different Antibiotics against Multidrug-resistant Bacteria. Naqvi, S.Z.H., U. Kiran, M.I. Ali, A. Jamal, A. Hameed, S. Ahmed, and N. Ali. International Journal of Nanomedicine, 2013. 8: p. 3187-3195. ISI[000323197400001].

[WOS]. OI_0830-091213.


56. Small Molecule Inhibitors of Trans-translation Have Broad-spectrum Antibiotic Activity. Ramadoss, N.S., J.N. Alumasa, L. Cheng, Y. Wang, S. Li, B.S. Chambers, H. Chang, A.K. Chatterjee, A. Brinker, I.H. Engels, and K.C. Keiler. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(25): p. 10282-10287. ISI[000321500200059].

[WOS]. OI_0830-091213.


57. Identification of a Small Molecule with Activity against Drug-resistant and Persistent Tuberculosis. Wang, F., D. Sambandan, R. Halder, J.N. Wang, S.M. Batt, B. Weinrick, I. Ahmad, P.Y. Yang, Y. Zhang, J. Kim, M. Hassani, S. Huszar, C. Trefzer, Z.K. Ma, T. Kaneko, K.E. Mdluli, S. Franzblau, A.K. Chatterjee, K. Johnson, K. Mikusova, G.S. Besra, K. Futterer, W.R. Jacobs, and P.G. Schultz. Proceedings of the National Academy of Sciences of the United States of America, 2013. 110(27): p. E2510-E2517. ISI[000321978000012].

[WOS]. OI_0830-091213.


58. Identification and Characterization of Antifungal Active Substances of Streptomyces hygroscopicus BS-112. Zhang, N., Z. Song, Y.H. Xie, P. Cui, H.X. Jiang, T. Yang, R.C. Ju, Y.H. Zhao, J.Y. Li, and X.L. Liu. World Journal of Microbiology and Biotechnology, 2013. 29(8): p. 1443-1452. ISI[000321977300011].

[WOS]. OI_0830-091213.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022